Szu-Liang Lai

Title: The Innovations of Szu-Liang Lai

Introduction

Szu-Liang Lai is a prominent inventor based in New Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of novel antibodies. With a total of five patents to his name, Lai's work has the potential to impact various medical applications.

Latest Patents

Among his latest patents is the invention titled "Anti-CD73 antibodies and use thereof." This invention relates to a novel antibody and its antigen-binding fragment, which specifically binds to human CD73 at designated epitopes. Another notable patent is for "Humanized anti-human neurotensin receptor 1 antibodies and their uses." This patent describes a humanized antibody or its antigen-binding fragment, along with methods for treating diseases related to NTSR1 activity and signaling.

Career Highlights

Szu-Liang Lai has worked with esteemed organizations such as the Development Center for Biotechnology and the National Health Research Institutes. His experience in these institutions has allowed him to advance his research and contribute to significant innovations in the field.

Collaborations

Lai has collaborated with notable colleagues, including Chu-Bin Liao and Yen-Yu Wu. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions.

Conclusion

Szu-Liang Lai's contributions to biotechnology through his patents and collaborations highlight his role as a key inventor in the field. His work continues to pave the way for advancements in medical treatments and therapies.